Fineline Cube

Follow:
14455 Articles
CompanyDrug

Chia Tai Tianqing’s Biosimilar Rituximab Approved by China’s NMPA for Lymphoma Treatments

CompanyDrug

Jiangsu Hengrui Pharmaceuticals Secures NMPA Approvals for SHR-2106 and HRS-1893 Clinical Trials

CompanyDeals

Galvanize Therapeutics Partners with Energenx Medical for Greater China Expansion

CompanyDrug

AstraZeneca Launches Calquence in China for Mantle Cell Lymphoma Treatment

CompanyDeals

Kangtai Biological Partners with Indian Pharmaceutical Giant for 13-Valent Pneumonia Vaccine

CompanyDeals

Medtronic Launches AiBLE Orthopedic Ecosystem and Partners with Allinmd Orthopedics in China

CompanyDeals

TYK Medicines Partners with WuXi STA for Comprehensive CMC Services

CompanyDeals

Beijing’s E-Health Now Secures Tens of Millions in Series B Financing

CompanyDeals

Boyi Biotech Secures Over RMB100 Million in Series A Financing Led by JOLMO

CompanyDeals

Mindray Partners with Vazyme Biotech to Develop Automated Infection Screening Solutions

CompanyDrug

Hisun Pharmaceutical’s SHP2 Inhibitor HS336 Gets NMPA Clinical Trial Approval

Policy / Regulatory

Hainan Boao Lecheng Introduces 319 Overseas Drugs and Devices, Reports Significant Growth